Log In
BCIQ
Print this Print this
 

Clearview Complete HIV 1/2

  Manage Alerts
Collapse Summary General Information
Company Chembio Diagnostics Inc.
DescriptionTest that detects HIV-1 and HIV-2 antibodies in human whole blood, serum and plasma
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDiagnose HIV infection
Regulatory Designation
PartnerAlere Inc.;
StatSure Diagnostic Systems Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$8,400.0M

$5,800.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/01/2016

$8,400.0M

$5,800.0M

0

Get a free BioCentury trial today